drugset / Trial / NCT01133795
Midodrine and Albumin for Cirrhotic Patients With Functional Renal Impairment
NaSingle-groupOpen-labelTreatment
Summary
The objective of the study was evaluate the effect of administration of midodrine and albumin on renal function in patients with cirrhosis and creatinine greater than 1,2mg/dl.
Timeline
- Start
- 2010-02
- Primary completion
- 2016-06
- Completion
- 2016-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Albumin | Protein / enzyme biologic | 40 g | Intravenous |
| Subject | Midodrine | Small molecule | 10 mg | Oral |